Regulatory Roles of Histone Deacetylation in Metabolic Stress-Induced Expression of Caspase Recruitment Domain-Containing Protein 9 (CARD9) in Pancreatic β-Cells
-
Published:2023-11-06
Issue:21
Volume:24
Page:15994
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Hali Mirabela1, Pinto Nelson1, Gleason Noah12, Kowluru Anjaneyulu12
Affiliation:
1. Biomedical Research Service, John D. Dingell VA Medical Center, Detroit, MI 48201, USA 2. Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
Abstract
CARD9, a scaffolding protein, has been implicated in the pathogenesis of metabolic diseases, including obesity and diabetes. We recently reported novel roles for CARD9 in islet β-cell dysregulation under duress of gluco (HG)- and glucolipotoxic (GLT) stress. CARD9 expression was also increased in β-cells following exposure to HG and GLT stress. The current study is aimed at understanding the putative roles of histone deacetylation in HG- and GLT-induced expression of CARD9. Using two structurally distinct inhibitors of histone deacetylases (HDACs), namely trichostatin (TSA) and suberoylanilide hydroxamic acid (SAHA), we provide the first evidence to suggest that the increased expression of CARD9 seen under duress of HG and GLT stress is under the regulatory control of histone deacetylation. Interestingly, the expression of protein kinase Cδ (PKCδ), a known upstream regulator of CARD9 activation, is also increased under conditions of metabolic stress. However, it is resistant to TSA and SAHA, suggesting that it is not regulated via histone deacetylation. Based on these data, we propose that targeting the appropriate HDACs, which mediate the expression (and function) of CARD9, might be the next step to further enhance our current understanding of the roles of CARD9 in islet dysfunction under metabolic stress and diabetes.
Funder
US Department of VA NIH Detroit Cardiovascular Research
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference40 articles.
1. Milazzo, G., Mercatelli, D., Di Muzio, G., Triboli, L., De Rosa, P., Perini, G., and Giorgi, F.M. (2020). Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes, 11. 2. King, J., Patel, M., and Chandrasekaran, S. (2021). Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective. Metabolites, 11. 3. Psilopatis, I., Garmpis, N., Garmpi, A., Vrettou, K., Sarantis, P., Koustas, E., Antoniou, E.A., Dimitroulis, D., Kouraklis, G., and Karamouzis, M.V. (2023). The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy. Cancers, 15. 4. Eckschlager, T., Plch, J., Stiborova, M., and Hrabeta, J. (2017). Histone Deacetylase Inhibitors as Anticancer Drugs. Int. J. Mol. Sci., 18. 5. Bocchi, L., Motta, B.M., Savi, M., Vilella, R., Meraviglia, V., Rizzi, F., Galati, S., Buschini, A., Lazzaretti, M., and Pramstaller, P.P. (2019). The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes. Int. J. Mol. Sci., 20.
|
|